Mesenchymal Stromal/Stem Cells-Derived Exosomes Therapy (MSC-Exos)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesenchymal Stromal/Stem Cells-Derived Exosomes Therapy (MSC-Exos), covering 2025-08-27 to 2025-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients [Phase 2]